480 related articles for article (PubMed ID: 29404280)
21. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
[TBL] [Abstract][Full Text] [Related]
22. New aspects of the infection mechanisms of Bacillus anthracis.
Zakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Kocik J
Ann Agric Environ Med; 2012; 19(4):613-8. PubMed ID: 23311776
[TBL] [Abstract][Full Text] [Related]
23. [Immunosuppressive action of the lethal toxin of Bacillus anthracis in mice].
Abalakin VA
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):94-9. PubMed ID: 2508379
[TBL] [Abstract][Full Text] [Related]
24. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins.
Rivera J; Cordero RJ; Nakouzi AS; Frases S; Nicola A; Casadevall A
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19002-7. PubMed ID: 20956325
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
Xu Q; Hesek ED; Zeng M
Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655
[TBL] [Abstract][Full Text] [Related]
26. Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice.
Glomski IJ; Corre JP; Mock M; Goossens PL
Infect Immun; 2007 Oct; 75(10):4754-61. PubMed ID: 17635863
[TBL] [Abstract][Full Text] [Related]
27. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.
Cote CK; Van Rooijen N; Welkos SL
Infect Immun; 2006 Jan; 74(1):469-80. PubMed ID: 16369003
[TBL] [Abstract][Full Text] [Related]
28. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against
Majumder S; Das S; Somani VK; Makam SS; Kingston JJ; Bhatnagar R
Front Immunol; 2019; 10():498. PubMed ID: 30941133
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial role for natural killer cells in host defense to Bacillus anthracis.
Gonzales CM; Williams CB; Calderon VE; Huante MB; Moen ST; Popov VL; Baze WB; Peterson JW; Endsley JJ
Infect Immun; 2012 Jan; 80(1):234-42. PubMed ID: 22006566
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis.
Bradburne C; Chung MC; Zong Q; Schlauch K; Liu D; Popova T; Popova A; Bailey C; Soppet D; Popov S
BMC Immunol; 2008 Nov; 9():67. PubMed ID: 19014542
[TBL] [Abstract][Full Text] [Related]
31. Frontline Science: Anthrax lethal toxin-induced, NLRP1-mediated IL-1β release is a neutrophil and PAD4-dependent event.
Greaney AJ; Portley MK; O'Mard D; Crown D; Maier NK; Mendenhall MA; Mayer-Barber KD; Leppla SH; Moayeri M
J Leukoc Biol; 2020 Sep; 108(3):773-786. PubMed ID: 32421904
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of isogenic variants of Bacillus anthracis with various content of virulence plasmids].
Barkova IA; Novozhenina AV; Barkov AM; Porokhnia SV; Tkachenko GA; Lipnitskiĭ AV
Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):17-22. PubMed ID: 25842948
[TBL] [Abstract][Full Text] [Related]
33. Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage.
Ali SR; Timmer AM; Bilgrami S; Park EJ; Eckmann L; Nizet V; Karin M
Immunity; 2011 Jul; 35(1):34-44. PubMed ID: 21683629
[TBL] [Abstract][Full Text] [Related]
34. Role of toxin functional domains in anthrax pathogenesis.
Brossier F; Weber-Levy M; Mock M; Sirard JC
Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
[TBL] [Abstract][Full Text] [Related]
35. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
[TBL] [Abstract][Full Text] [Related]
36. A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.
Kachura MA; Hickle C; Kell SA; Sathe A; Calacsan C; Kiwan R; Hall B; Milley R; Ott G; Coffman RL; Kanzler H; Campbell JD
J Immunol; 2016 Jan; 196(1):284-97. PubMed ID: 26608924
[TBL] [Abstract][Full Text] [Related]
37. Anthrax toxins: a weapon to systematically dismantle the host immune defenses.
Tournier JN; Rossi Paccani S; Quesnel-Hellmann A; Baldari CT
Mol Aspects Med; 2009 Dec; 30(6):456-66. PubMed ID: 19560486
[TBL] [Abstract][Full Text] [Related]
38. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.
Heninger S; Drysdale M; Lovchik J; Hutt J; Lipscomb MF; Koehler TM; Lyons CR
Infect Immun; 2006 Nov; 74(11):6067-74. PubMed ID: 16923785
[TBL] [Abstract][Full Text] [Related]
39. Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to Bacillus anthracis.
Terra JK; France B; Cote CK; Jenkins A; Bozue JA; Welkos SL; Bhargava R; Ho CL; Mehrabian M; Pan C; Lusis AJ; Davis RC; LeVine SM; Bradley KA
PLoS Pathog; 2011 Dec; 7(12):e1002469. PubMed ID: 22241984
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins.
Klezovich-Bénard M; Corre JP; Jusforgues-Saklani H; Fiole D; Burjek N; Tournier JN; Goossens PL
PLoS Pathog; 2012 Jan; 8(1):e1002481. PubMed ID: 22253596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
